
Arbutus Biopharma Corporation ABUS
€ 3.69
3.73%
Geschäftsbericht 2025
hinzugefügt 23.03.2026
Arbutus Biopharma Corporation EV/EBITDA 2011-2026 | ABUS
EV/EBITDA Jährlich Arbutus Biopharma Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.41 | -4.54 | -1.84 | -2.47 | -3.47 | -1.25 | 0.453 | -15.5 | -11.3 | 0.558 | -1.64 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.558 | -15.5 | -4.03 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
Aligos Therapeutics
ALGS
|
-2.41 | $ 8.51 | 6.44 % | $ 84.1 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 3.63 | -2.42 % | $ 8.73 B | ||
|
I-Mab
IMAB
|
595 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
4.22 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Applied Therapeutics
APLT
|
-0.476 | - | - | $ 8.42 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
BioNTech SE
BNTX
|
4.1 | $ 97.45 | 2.04 % | $ 27.2 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
17.3 | $ 20.73 | 1.74 % | $ 969 M | ||
|
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
-2.4 | $ 1.42 | 1.42 % | $ 365 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | ||
|
Allakos
ALLK
|
-1.56 | - | - | $ 28.6 M | ||
|
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 2.91 | -0.34 % | $ 4.79 M | ||
|
Aquestive Therapeutics
AQST
|
-7.26 | $ 4.16 | 1.84 % | $ 445 M | ||
|
Aravive
ARAV
|
-0.158 | - | -13.39 % | $ 1.45 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-4.86 | $ 23.99 | -0.91 % | $ 3.05 B | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
0.185 | $ 32.25 | 0.03 % | $ 2.14 B | ||
|
Autolus Therapeutics plc
AUTL
|
-1.38 | $ 1.48 | -1.01 % | $ 394 M | ||
|
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M | ||
|
Cidara Therapeutics
CDTX
|
-1.47 | - | - | $ 1.41 B | ||
|
AVROBIO
AVRO
|
0.957 | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-1.92 | $ 2.58 | 1.12 % | $ 16.2 M | ||
|
AstraZeneca PLC
AZN
|
76.5 | - | - | $ 96.9 B | ||
|
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | ||
|
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-5.59 | - | -2.5 % | $ 5.88 M | ||
|
BeiGene, Ltd.
BGNE
|
-208 | - | 0.49 % | $ 251 B | ||
|
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | ||
|
Akari Therapeutics, Plc
AKTX
|
-249 | $ 3.79 | -0.98 % | $ 255 B | ||
|
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | ||
|
Baudax Bio
BXRX
|
-1.99 | - | 0.59 % | $ 63 K | ||
|
Cabaletta Bio
CABA
|
0.778 | $ 3.19 | 1.76 % | $ 321 M | ||
|
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | ||
|
CymaBay Therapeutics
CBAY
|
-1.63 K | - | - | $ 3.45 B | ||
|
Aileron Therapeutics
ALRN
|
-0.0369 | - | 10.36 % | $ 9.8 M |